CD73-derived adenosine at the blood-brain barrier confers protection in a mouse model of ischemic stroke
This study demonstrates that restoring CD73 expression specifically in mouse blood-brain barrier endothelial cells protects against ischemic stroke by converting pro-inflammatory ATP into anti-inflammatory adenosine, thereby reducing infarct volume and mortality while promoting an inflammation-resolving immune response.